Publications

Search our bibliography using the filters on the right-hand side.

Displaying 151 through 200 of 323 publications.

Yu Y, Meyers JL, Kaila S, Dhamane A, Candrilli SD. Assessment of spirometry testing and inpatient readmission in patients with chronic obstructive pulmonary disease. Poster presented at the 2014 ISPOR 19th Annual International Meeting; June 3, 2014.

Bollu V, Nelson LM, Williams VS, Stensland MD, Stull DE. Symptom response profiles for patients with chronic obstructive pulmonary disease initiating nebulized arformoterol tartrate or placebo. Poster presented at the 2014 ISPOR 19th Annual International Meeting; June 3, 2014.

Meyers JL, Yu Y, Kaila S, Dhamane A, Candrilli SD. Factors associated with chronic obstructive pulmonary disease-related inpatient readmissions. Poster presented at the 2014 ISPOR 19th Annual International Meeting; May 2014.

Patel JG, Nagar SP, Dalal AA. Indirect costs in chronic obstructive pulmonary disease: a review of the economic burden on employers and individuals in the United States. Int J Chron Obstruct Pulmon Dis. 2014 Mar;19(9):289-300.

Stanford RS, Nagar SP, Lin X, O'Conner R. Impact of change in inhaled corticosteroids/long-acting beta agonist combination (ICS/LABA) use on the risk of asthma exacerbations in asthma patients within a medical group. Poster presented at the 2014 AAAAI Annual Meeting; February 2014. San Diego, CA. [abstract] J Allergy Clin Immunol. 2014 Feb; 133(2):AB7.

Twiss J, McKenna S, Rouse M. Using Rasch analysis to co-calibrate scores from outcome measures specific to asthma (ALIS), chronic obstructive pulmonary disease (LCOPD) and pulmonary hypertension (CAMPHOR). Poster presented at the 2013 ISPOR 16th Annual European Congress; November 2013. Dublin, Ireland. [abstract] Value Health. 2013 Nov; 16(7):A605. doi: 10.1016/j.jval.2013.08.1724

Marcano Belisario JS, Huckvale K, Greenfield G, Car J, Gunn LH. Smartphone and tablet self management apps for asthma. Cochrane Database Syst Rev. 2013 Nov;2013(11):CD010013. doi: 10.1002/14651858.CD010013.pub2

Taychakhoonavudh S, Parikh R, Ganduglia C, Franzini L. Geographic variation in asthma admission rates across hospital referral regions in Texas: an analysis of private insurance population between 2008 and 2011. Presented at the 141st American Public Health Association Annual Meeting; November 2013. Boston, MA.

Tennis PS, Johannes CB, Camargo C, Sturmer T, Lanes S, Brown J, Andrews EB, Davis K, Schatz M. Feasibility of ruling out small treatment-associated increase in asthma mortality risk. Poster presented at the 29th International Conference on Pharmacoepidemiology and Therapeutic Risk Management; August 2013. Montreal, Canada. [abstract] Pharmacoepidemiol Drug Saf. 2013 Aug; 22(Suppl 1):S34-5. doi: 10.1002/pds.3512

Barrett AM, Clark MJ, DeMuro C, Esser D. Proxy-reported questionnaires for young children with asthma: a structured review. Eur Respir J. 2013 Aug 1;42(2):513-26.

Midkiff K, Johannes C, Tennis P, Calingaert B, McQuay L, Harris DH, Andrews E. Identifying causes of death in a large cohort of asthma patients. Poster presented at the 29th International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 2013. Montreal, Canada. [abstract] Pharmacoepidemiol Drug Saf. 2013 Aug; 22(Suppl 1):300.

Johannes C, McQuay L, Tennis P, Camargo CA, Schatz M, Midkiff K, Lanes S, DiSantostefano R, Davis K. Characteristics of initiators of asthma maintenance medications in 10 health care populations. Poster presented at the 29th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 2013. Montreal. [abstract] Pharmacoepidemiol Drug Saf. 2013 Aug; 22(Suppl 1):273-4.

Norback D, Zock JP, Plana E, Heinrich J, Svanes C, Sunyer J. Mould and dampness in dwelling places, and onset of asthma: the population-based cohort ECRHS. Occup Environ Med. 2013 May;70(5):325-31.

Bateman E, Esser D, Chirila C, Fernandez MM, Fowler A, Moroni-Zentgraf P, FitzGerald J. Systematic review and meta-analysis of the magnitude of the effect on the AQLQ and ACQ in asthma clinical trials. Poster presented at the ERS Annual Congress; 2013.

Sunyer J, Viana M, Alvarez-Pedrerol M, Rivas I, Forns J, Querol X. School air in a traffic city such Barcelona, the BREATHE Study. Presented at the DOHaD 2012 Satellite Meeting; December 6, 2012. Rotterdam, The Netherlands.

Myers RA, Himes BE, Gignoux CR, Yang JJ, Gauderman WJ, Rebordosa C. Further replication studies of the eve consortium meta-analysis identifies 2 asthma risk loci in European Americans. J Allergy Clin Immunol. 2012 Dec;130(6):1294-301.

Heyes A, Lebiecki J, Serup-Hansen N, Andreasen J. Identification of cost-drivers in the management of patients with allergic rhinitis. Poster presented at the XXXI Congress of the European Academy of Allergy and Clinical Immunology; June 2012. Geneva, Switzerland. [abstract] Allergy. 2012 Nov; 67(S96):344.

Christiansen CF, Pedersen L, Sorensen HT, Rothman KJ. Methods to assess seasonal effects in epidemiological studies of infectious diseases-exemplified by application to the occurrence of meningococcal disease. Clin Microbiol Infect. 2012 Oct 1;18(10):963-9.

Midkiff K, Calingaert B, Tennis P, Harris DH, Andrews EB. Using an automated computer-based algorithm to increase the efficiency of selecting the best match from national death index linkage results. Poster presented at the 28th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 2012. Barcelona. [abstract] Pharmacoepidemiol Drug Saf. 2012 Sep 5; 21(Suppl 3):S396.

McKenna SP, Twiss J, Crawford SR, Oprandi NC, Tammaru M, Miravitlles M. The living with chronic obstructive pulmonary disease scale was successfully adapted for use in southern european (Italian and Spanish) and eastern european (Russian) cultures. J Clin Epidemiol. 2012 Aug;65(8):906-14.

Sunyer J, Garcia-Esteban R, Castilla AM, Aurrekoetxea JJ, Iniguez C, Tardon A, Espada M, Lertxundi A, Chatzi L, Rebagliato M, Kogevinas M, INMA Project. Exposure to second-hand smoke and reproductive outcomes depending on maternal asthma. Eur Respir J. 2012 Aug;40(2):371-6. doi: 10.1183/09031936.00091411

Leynaert B, Sunyer J, Garcia-Esteban R, Svanes C, Jarvis D, Cerveri I, Dratva J, Gislason T, Heinrich J, Janson C, Kuenzli N, de Marco R, Omenaas E, Raherison C, Gomez Real F, Wjst M, Zemp E, Zureik M, Burney PG, Anto JM, Neukirch F. Gender differences in prevalence, diagnosis and incidence of allergic and non-allergic asthma: a population-based cohort. Thorax. 2012 Jul;67(7):625-31. doi: 10.1136/thoraxjnl-2011-201249

Rycroft CE, Heyes A, Lanza L, Becker K. Epidemiology of chronic obstructive pulmonary disease: a literature review. Int J Chron Obstruct Pulmon Dis. 2012 Jul 1;7:457-94.

DiFranza JR, Masaquel A, Barrett AM, Colosia AD, Mahadevia PJ. Systematic literature review assessing tobacco smoke exposure as a risk factor for serious respiratory syncytial virus disease among infants and young children. BMC Pediatr. 2012 Jun 1;12:81.

Dalal AA, Shaw MB, D'Souza AO, Lunacsek OE, Nagar SP, Crater GD. Observational study of the outcomes and costs of initiating maintenance therapies in patients with moderate exacerbations of COPD. Resp Res. 2012 May;31(13):41.

Morales E, Bustamante M, Vilahur N, Escaramis G, Montfort M, de Cid R, Garcia-Esteban R, Torrent M, Estivill X, Grimalt JO, Sunyer J. DNA hypomethylation at ALOX12 is associated with persistent wheezing in childhood. Am J Respir Crit Care Med. 2012 May 1;185(9):937-43. doi: 10.1164/rccm.201105-0870OC

Colosia AD, Masaquel A, Hall CB, Barrett AM, Mahadevia PJ, Yogev R. Residential crowding and severe respiratory syncytial virus disease among infants and young children: a systematic literature review. BMC Infect Dis. 2012 Apr 1;12:95.

Sansgiry SS, Joish VN, Boklage S, Goyal RK, Chopra P, Sethi S. Economic burden of Pseudomonas aeruginosa infection in patients with cystic fibrosis. J Med Econ. 2012;15(2):219-24. doi: 10.3111/13696998.2011.638954

Williams LK, Peterson EL, Wells K, Ahmedani BK, Kumar R, Burchard EG, Chowdhry VK, Favro D, Lanfear DE, Pladevall M. Quantifying the proportion of severe asthma exacerbations attributable to inhaled corticosteroid nonadherence. J Allergy Clin Immunol Pract. 2011 Dec 1;128(6):1185-91.

Stull DE, Wiklund I, Gale R, Capkun-Niggli G, Houghton K, Jones P. Application of latent growth and growth mixture modeling to identify and characterize differential responders to treatment for COPD. Contemp Clin Trials. 2011 Nov 1;32(6):818-28.

Stull DE, Houghton KF, Gale R, Wiklund I, Capkun-Niggli G, Jones P. Application of innovative methods to identify and characterize differential responders in clinical trials of COPD: the use of mixture models. Poster presented at the 2011 ISPOR 14th Annual European Congress; November 2011. Madrid, Spain. [abstract] Value Health. 2011 Nov; 14(7):A501-2.

Palsgrove A, Houghton KF, Hareendran A, Schaefer M, Setyawan J, Mocarski M, Carson R, Make B. The development of the early morning symptoms of COPD instrument (EMSCI). Poster presented at the 2011 ISPOR 14th Annual European Congress; November 16, 2011. [abstract] Value Health. 2011 Nov; 14(7):A496-7.

Clark M, Hofmann A, Tabberer M, Martin S. Development and content validity of the COPD device preference questionnaire. Poster presented at the 2011 ISPOR 14th Annual European Congress; November 9, 2011. [abstract] Value Health. 2011 Nov; 14(7):A255.

Mansfield CA, Viswanathan M, Woodell C, Nourani V, Ohadike Y, Kennedy Lesch J, Malveaux FJ, Bryant-Stephens T, Findley S, Lara M, Matiz A, Valencia GR, Rosenthal M, Persky VW, Uyeda K, Williams R, Banda E, Ramirez-Diaz E, Reyes BM, Montoya J, West C. Outcomes from a cross-site evaluation of a comprehensive pediatric asthma initiative incorporating translation of evidence-based interventions. Health Promot Pract. 2011 Nov;12((Suppl 1)):34S-51S.

Findley S, Rosenthal M, Bryant-Stephens T, Damitz M, Lara M, Mansfield CA, Matiz A, Nourani V, Peretz P, Persky VW, Valencia VR, Uyeda K, Viswanathan M. Community-based care coordination: practical applications for childhood asthma. Health Promot Pract. 2011 Nov;12((6 (Suppl 1)):52S-62S.

Viswanathan M, Lux LJ, Lohr KN, Swinson Evans TM, Rojas Smith L, Woodell CL, Mansfield CA, Ohadike Y, Lesch J, Malveaux FJ. Translating evidence-based interventions into practice: the design and development of the Merck Childhood Asthma Network, Inc. (MCAN). Health Promot Pract. 2011 Nov;12((6 Suppl 1)):9S-19S.

Viswanathan M, Mansfield CA, Rojas Smith L, Woodell CL, Darcy NM, Ohadike Y, Lesch JK, Malveaux FJ. Cross-site evaluation of a comprehensive pediatric asthma project: the Merck Childhood Asthma Network, Inc. (MCAN). Health Promot Pract. 2011 Nov;12((6 Suppl 1)):20S-33S.

Rebordosa C, Kogevinas M, Guerra S, Castro-Giner F, Jarvis D, Cazzoletti L. ADRB2 Gly16Arg polymorphism, asthma control and lung function decline. Eur Respir J. 2011 Nov;38(5):1029-35.

Crawford SR, McKenna SP, Twiss J, Tammaru M, Oprandi NC. Further developments of the Asthma Life Impact Scale (ALIS). Poster presented at the 2011 ISPOR 14th Annual European Congress; November 2011. [abstract] Value Health. 2011 Nov; 14(7):A497. doi: 10.1016/j.jval.2011.08.1440

Crawford SR, McKenna SP, Twiss J, Tammaru M, Oprandi NC. Further developments of the Living with Chronic Obstructive Pulmonary Disease (LCOPD). Poster presented at the 2011 ISPOR 14th Annual European Congress; November 2011. [abstract] Value Health. 2011 Nov; 14(7):A497.

McKenna SP, Meads DM, Doward LC, Twiss J, Pokrzywinski R, Revicki D, Hunter CJ, Glendenning GA. Development and validation of the living with chronic obstructive pulmonary disease questionnaire. Qual Life Res. 2011 Sep 1;20(7):1043-52.

Dalal AA, Candrilli SD, Davis KL. Outcomes and costs associated with initial maintenance therapy with fluticasone propionate-salmeterol xinafoate 250 ?g/50 ?g combination versus tiotropium in commercially insured patients with copd. Manag Care. 2011 Aug 1;20(8):46-55.

Fondell E, Balter O, Rothman KJ. Dietary intake and supplement use of vitamins C and E and upper respiratory tract infection. J Am Coll Nutr. 2011 Aug 1;30(4):248-58.

Evans MF, Poulos C, Smith VK. Who counts in evaluating the effects of air pollution policies on households? Non-market valuation in the presence of dependencies. J Environ Econ Manage. 2011 Jul 1;62(1):65-79.

Dalal AA, Nelson L, Gilligan TM, McLeod LD, Lewis SE, DeMuro C. Measurement comparability between paper and alternate versions: recommended assessment steps using the lung function questionnaire as an example. Poster presented at the 2011 ISPOR 16th Annual International Meeting; May 25, 2011. [abstract] Value Health. 2011 May; 14(3):A145.

Mintz ML, Yawn BP, Mannino DM, Donohue JF, Hanania NA, Grellet CA, Gilsenan AW, McLeod LD, Dalal AA, Raphiou IH, Prillaman BA, Crater GD, Cicale MJ, Mapel DW. Prevalence of airway obstruction assessed by lung function questionnaire. Mayo Clin Proc. 2011 May 1;86(5):375-81.

Palsgrove A, Schaefer M, Hareendran A, Houghton KF, Mocarski M, Carson R, Make B. The development of a patient-reported outcome instrument to evaluate nighttime symptoms of COPD. Poster presented at the 2011 ISPOR 16th Annual International Meeting; May 2011. Baltimore, MD. [abstract] Value Health. 2011 May; 14(3):A141-2. doi: 10.1016/j.jval.2011.02.788

Mitra D, Baldwin M, Kessabi S, Meyers JL, Candrilli SD. Time to treatment discontinuation, switching, and augmentation among patients with chronic obstructive pulmonary disease in a real-world setting. Poster presented at the 2011 American Thoracic Society International Conference; May 2011.

Mitra D, Baldwin M, Kessabi S, Meyers JL, Candrilli SD. Real-world medication treatment patterns among patients with chronic obstructive pulmonary disease: evidence from US managed care data. Poster presented at the 2011 American Thoracic Society International Conference; May 2011.

Gilligan TM, Nelson L, Dalal AA, McLeod LD. Visually evaluating the measurement comparability between paper-based and alternate versions of administration of the lung function questionnaire. Poster presented at the 2011 ISPOR 16th Annual International Meeting; May 25, 2011. [abstract] Value Health. 2011 May; 14(3):A153.